Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a6593d17e5fe557301f9dede583b574 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 |
filingDate |
2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d3a9e8e2d7b30d15372448d45882bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444f2a8575897670a2c42cbf95ea70ce |
publicationDate |
2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-3174547-A1 |
titleOfInvention |
Active substances for medical use |
abstract |
The subject matter of the present invention relates to an amine (AM) according to the general formula (I); a carbonic acid adduct (KA) and a pharmaceutical composition (PZ) for use in the treatment of atypical pneumonia and for use in the therapy of viral diseases. |
priorityDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |